PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsotitis externa
MeSH D010032 - otitis externa
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010031:Otitis
0 Companies
0 Drugs
Success rate
D010032: 
Otitis externa
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Alcon ResearchDexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1986-11-17   
Neomycin, Polymyxin b Statrol  1984-11-30   
ALK-AbellóCiprofloxacin Otiprio 2029-04-21 2015-12-10   
AllerganPrednisolone, Neomycin, Polymyxin b Poly-pred  1982-01-01   
Trimethoprim, Polymyxin b Polytrim  1988-10-20   
Ciprofloxacin Ciprofloxacin  2005-01-21   
Neomycin, Polymyxin b Neomycin Polymyxin B  1986-04-08   
Gramicidin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Gramicidin  1987-06-11   
Hydrocortisone, Neomycin, Polymyxin b Otocort  1982-01-01   
Altaire PharmaceuticalsCiprofloxacin Ciprofloxacin  2018-05-03   
AltanaHydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Amneal PharmaceuticalsCiprofloxacin Ciprofloxacin  2004-06-09   
Amring PharmaceuticalsCiprofloxacin Ciprofloxacin  2008-01-16   
Hydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  2005-10-31   
ANI PharmaceuticalsCiprofloxacin Ciprofloxacin  2010-11-30   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
60%
3/5
Phase 3
31%
9/29
Approved: 7Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Alcon Research
Allergan
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use